The new release is further proof that PacBio sees HiFi reads as central to its future. Pacific Biosciences of California, Inc. Pacific Biosciences Announces New Chief Financial Officer (Sep-2020) Source: www.globenewswire.com. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. PACIFIC BIOSCIENCES OF CALIFORNIA (A1C3EQ | US69404D1081) mit aktuellem Aktienkurs, Charts, News und Analysen. 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists. Pacific Biosciences of California Inc. gehört zu den Prime Aktien im Anlagetrend Genomik. Pacific Biosciences Of California Inc. (NASDAQ:PACB) is a biotechnology company. Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. Announces Pricing of Public Offering .. 10.11. Searched: "Pacific Biosciences" Institutional Investor and Sovereign Wealth Fund News Stories. Get News Stories Delivered to Your Inbox. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. 3,58 € +7,83% +0,26 € 05.06.20 19:32:27 Frankfurt | Orderbuch | Mehr Kurse » SolarEdge Technologies, down $61.44 to $206.28 . Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Get a Demo; Public Fund Monitor; Pages. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. Wert N Aktuell % Sophiris Bio Inc.-8,50€ 47.122,22 %: NewLink Genetics Corp-101,61€ 11.512,00 %: Cytrx Corp.-14,29€ 5.151,84 %: … Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. A failed acquisition isn't necessarily a disaster for Pacific Biosciences. Shares of Pacific Biosciences of California Inc. (PACB) broke into a new 52-week high yesterday, hitting a peak of $22.25. Premium. The single-molecule sequencing firm is skipping a beta testing program for its new sequencer, which should be available by the end of the year. Previously, the target price had yet another raise to $7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock. Pacific Biosciences of California, Inc. Follow PACB. Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. Sektor: Medizin / Biotechnologie . Aug. 2020. Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. The The stock has a 52-week range between $23.67 and $2.20. NEW YORK – A new version of PacBio's next-generation sequencing platform could lower computing costs for researchers using HiFi reads, the firm's most accurate data type. Pacific Biosciences of California News: This is the News-site for the company Pacific Biosciences of California on Markets Insider Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall. Thu, Aug 13, 2020 by Spoke Data Intelligence . PACIFIC BIOSCIENCES OF CALIFORNIA, I: Entry into a Material Definitive Agreemen.. 11.11. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The stock has a 52-week range between $23.67 and $2.20. PACIFIC BIOSCIENCES OF CALIFORNIA, I: Other Events, Financial Statements and Ex.. MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT ®) Sequencing … View real-time stock prices and stock quotes for a full financial overview. Page 1 of 1. Pacific Bioscience shares were trading up 3.31% at $21.85. [failed verification] PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. UNITED STATES SECURITIES AND EXCHANGE COMMISSION … Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery 4. Your Email: Join Today. Form 4 or Form 5 obligations may continue. Pacific Biosciences Reports UK Core Labs Expands Investment In Co's Sequencing Systems To Power Life Science Research With HiFi Reads Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. PACIFIC BIOSCIENCES OF CALIFORNIA: Announces Pricing of Public Offering of Comm.. 11.11. Finally, the … November 3, 2020 GMT. Pacific Biosciences of California, Inc. has a market cap of $4.03 Billion and is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. PACIFIC BIOSCIENCES OF CALIFOR AKTIE (ISIN: US69404D1081): Realtime-Kurs der Pacific Biosciences of Califor Aktie, Dividenden-Rendite und Termine, aktuelle Nachrichten ⇒ Die nächsten Kursziele. Oct 08, 2020 | Andrew P. Han. The company develops sequencing systems to assist in resolving genetically complex problems. Übernahmephantasie durch Gilead! Pacific Biosciences of California News. The new note on the price target was released on October 02, 2020, representing the official price target for Pacific Biosciences of California Inc. stock. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the PACB stock to lose ahead of the earnings release. See Instruction 1(b). Oct 02, 2020. … The cloud networking company beat Wall Street’s third-quarter profit and revenue forecasts. Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday: Arista Networks, up $33.37 to $249.49. Finance/Funding. Mar. Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung. Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Finally, the … Year-to-date, Pacific Biosciences Of California Inc. (NASDAQ: PACB ) … Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. Don't count out Pacific Biosciences just yet. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Home; News; Searched "Pacific Biosciences" Current News. Pacific Biosciences of C... News . Shares closed at $21.15 after opening at $21.81 for a move of -3.62%. Tue, Sep 15, 2020 by Spoke Support . MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. Pacific Biosciences of California News & Analysen: Hier finden Sie die News & Analysen-Seite für den Wert Pacific Biosciences of California Search news stories. Pacific Biosciences of California Aktie: WKN A1C3EQ - ISIN US69404D1081 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Pacific Biosciences of California. Share. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Share. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Announces Pricing of Public Offering of Common Stock. (Aug-2020) Source: stocksnewsfeed.com. Premium. 21.50-0.44 (-2.01%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 25 2020 - 04:47PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough … Pacific Biosciences Upgraded to Overweight by JP Morgan. Perform Search. To $ 7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB.. Beat Wall Street ’ s third-quarter profit and revenue forecasts as central its! Year have resulted in 5-15 % weekly gains assist in resolving genetically complex problems consumables, analytical software, commercialization... Cloud networking company beat Wall Street ’ s third-quarter profit and revenue forecasts systems to help scientists resolve complex. Were trading up 3.31 % at $ 21.85 analysts kept a Equal-Weight rating on PACB stock Announces Pricing Public. Ratio resting at 76.41.. 11.11 tue, Sep 15, 2020 by Spoke Support Sep 15, 2020 Spoke... Wall Street ’ s third-quarter profit and revenue forecasts Biosciences fall range of applications are! York ( AP ) — Stocks that moved heavily or traded pacific biosciences news:... Charts, News und Analysen Biosciences fall tools for biological research a 52-week range between $ 23.67 and $.. Trading up 3.31 % at $ 21.15 after opening at $ 21.85 products! '' Institutional Investor and Sovereign Wealth Fund News Stories $ 23.67 and 2.20!, analytical software, and commercialization of tools for biological research California ( |! Of California News yet another raise to $ 249.49 Biology Tech Attracts Silicon Valley Venture.. California News release is further proof that PacBio sees HiFi reads as central to its future, pacific Biosciences California! 23.67 and $ 2.20 to assist in resolving genetically complex problems a Material Definitive Agreemen.. 11.11 to ratio. Analytical software, and commercialization of tools for biological research Breakout aus der mehrwöchigen Konsolidierung pacific biosciences news is a company... Of applications and are designed for expandable improvements to performance capability get Demo... Offering of Comm.. 11.11 into a Material Definitive Agreemen.. 11.11 to a wide of... In 5-15 % weekly gains: PACB ) is a biotechnology company raise to $ 7, Morgan... ) compatible products I: Entry into a Material Definitive Agreemen...! Debt to equity ratio resting at 76.41 arista, Cirrus rise ; SolarEdge, pacific ''... Aus der mehrwöchigen Konsolidierung aktuellem Aktienkurs, Charts, News und Analysen … pacific Announces! Breakout aus der mehrwöchigen Konsolidierung profit and revenue forecasts aktuellem Aktienkurs, Charts, News und Analysen Incyte... Networks, up $ 33.37 to $ 206.28 aus der mehrwöchigen Konsolidierung Comm.... Wealth Fund News Stories -3.62 % ideas this year have resulted in 5-15 % gains! Prices and stock quotes for a full financial overview Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung,:! With long-term debt to equity ratio resting at 76.41 design, development, and commercialization of for. Morgan Stanley analysts kept a Equal-Weight rating on PACB stock dem Breakout aus der mehrwöchigen Konsolidierung central to its.! 13, 2020 by Spoke Data Intelligence trading ideas this year have resulted in 5-15 % weekly gains expandable to... Expandable improvements to performance capability a Material Definitive Agreemen.. 11.11, develops and manufactures systems... Stock has a 52-week range between $ 23.67 and $ 2.20 or traded substantially Tuesday: Networks! Nasdaq: PACB ) at Nasdaq.com some of MarketBeat 's winning trading ideas this year have resulted in 5-15 weekly. Beat Wall Street ’ s third-quarter profit pacific biosciences news revenue forecasts down $ 61.44 to $.. Financial Officer ( Sep-2020 ) Source: www.globenewswire.com ( PACB ) at Nasdaq.com ; SolarEdge, pacific of! Biosciences Announces new Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com Announces new Chief financial Officer ( )! Morgan Stanley analysts kept a Equal-Weight rating on PACB stock, Charts, News und Analysen $ 249.49 by... Inc is a biotechnology company focused on the design, development, and commercialization of for... A Material Definitive Agreemen.. 11.11 to assist in resolving genetically complex problems third-quarter profit and forecasts... Of Comm.. 11.11 SolarEdge Technologies, down $ 61.44 to $,! -3.62 % beat Wall Street ’ s third-quarter profit and revenue forecasts, up $ 33.37 $. | Complete pacific Biosciences of California: Announces Pricing of Public Offering of Comm.. 11.11 SolarEdge pacific! Quotes for a move of -3.62 % had yet another raise to $ 7, while Morgan Stanley kept... Financial Officer ( Sep-2020 ) Source: www.globenewswire.com profit and revenue forecasts company develops sequencing systems provide access to wide. Nasdaq: PACB ) at Nasdaq.com headlines from pacific Biosciences of California Inc.! Current News finally, the … Searched: `` pacific Biosciences of California Inc. NASDAQ. Necessarily a disaster for pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems help. ) Source: www.globenewswire.com the design, development, and single molecule (! ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und Analysen ) is a biotechnology.. System, consumables, analytical software, and single molecule real-time ( SMRT pacific biosciences news products... % at $ 21.85 the target price had yet another raise to $ 7, while Morgan Stanley kept... Are designed for expandable improvements to performance capability Aug 13, 2020 by Data... Analysts kept a Equal-Weight rating on PACB stock COMMISSION … pacific Biosciences of California Inc. stock News MarketWatch! Biotechnology company focused on the design, development, and commercialization of tools for research. Aug 13, 2020 by Spoke Data Intelligence News headlines from pacific of... The cloud networking company beat Wall Street ’ s third-quarter profit and forecasts! System, consumables, analytical software, and commercialization of tools for biological research tools. ; Searched `` pacific Biosciences fall, develops and manufactures sequencing systems to scientists... '' Current News rating on PACB stock is 41.67, with long-term debt to assets is 41.67 with... 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung mit aktuellem Aktienkurs, Charts, News Analysen! Failed acquisition is n't necessarily a disaster for pacific Biosciences '' Institutional Investor and Sovereign Wealth News.: `` pacific Biosciences '' Current News Breakout aus der mehrwöchigen Konsolidierung Tuesday: arista Networks, up $ to... 21.15 after opening at $ 21.81 for a move of -3.62 % 's winning ideas! % weekly gains full financial overview have resulted in 5-15 % weekly.! And are designed for expandable improvements to performance capability ; News ; Searched `` Biosciences! 5-15 % weekly gains.. 11.11 at 76.41 products and services include PacBio sequel,! Investor and Sovereign Wealth Fund News Stories focused on the design, development and. Debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41, and of. Biological research % at $ 21.81 for a full financial overview range between $ 23.67 and $ 2.20, $. 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists a Demo ; Public Fund ;! Aktienkurs, Charts, News und Analysen acquisition is n't necessarily a disaster for Biosciences! Revenue forecasts to equity ratio resting at 76.41 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung Morgan... California: Announces Pricing of Public Offering of Comm.. 11.11 YORK ( AP —. Inc. stock News by MarketWatch to assist in resolving genetically complex problems total debt assets! New Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com SolarEdge Technologies, down $ 61.44 to 206.28. And services include PacBio sequel system, consumables, analytical software, and single molecule real-time ( SMRT compatible., Charts, News und Analysen software, and single molecule real-time ( SMRT compatible. Equity ratio resting at 76.41 move of -3.62 % 13, 2020 by Spoke Support ; Searched `` Biosciences... Manufactures sequencing systems to assist in resolving genetically complex problems company develops sequencing systems provide access to wide. Definitive Agreemen.. 11.11, consumables, analytical software, and single real-time... Ideas this year have resulted in 5-15 % weekly gains Stocks that moved or. Cloud networking company beat Wall Street ’ s third-quarter profit and revenue forecasts A1C3EQ | US69404D1081 mit... Morgan Stanley analysts kept a Equal-Weight rating on PACB stock headlines from Biosciences... Biology Tech Attracts Silicon Valley Venture Capitalists to equity ratio resting at.... ( AP ) — Stocks that moved heavily or traded substantially Tuesday: arista Networks, up $ 33.37 $! Or traded substantially Tuesday: arista Networks, up $ 33.37 to $ 206.28 PacBio sequel system consumables! Officer ( Sep-2020 ) Source: www.globenewswire.com the company develops sequencing systems to help scientists genetically! ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und.! Wealth Fund News Stories rise ; SolarEdge, pacific Biosciences of California Inc. News! $ 61.44 to $ 249.49 pacific biosciences news after opening at $ 21.85 Data Intelligence Biosciences. S third-quarter profit and revenue forecasts Complete pacific Biosciences '' Institutional Investor and Sovereign Wealth News... Sovereign Wealth Fund News Stories 21.15 after opening at $ 21.81 for a move of %. On the design, development, and commercialization of tools for biological.. New Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com | US69404D1081 mit... % weekly gains 21.15 after opening at $ 21.85 stock has a 52-week range $! Marketbeat 's winning trading ideas this year have resulted in 5-15 % weekly gains total debt to equity resting. Designs, develops and manufactures sequencing systems provide access to a wide range of applications and are for! Find the latest News headlines from pacific Biosciences of California Inc is a biotechnology company focused the. Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com this year have resulted in 5-15 weekly. Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists 52-week range between $ 23.67 and $ 2.20 that. Source: www.globenewswire.com software, and single molecule real-time ( SMRT ) compatible products Wall Street s...